Table 4.
Adverse events in haematopoietic stem cell transplantation (HSCT) patients (n = 8).
| Event | |
| All recorded events, n | 187 |
| All events possibly treatment related, n | 4 |
| Events per patient (min to max), n | 5 to 35 |
| Severity (% of events) | |
| Mild | 58 |
| Moderate | 25 |
| Severe | 17 |
| Non-serious events possibly treatment related, na | 4 |
| Supraventricular extrasystoles | 1 |
| ALT increased | 1 |
| AST increased | 1 |
| γ-Glutarate increased | 1 |
| Serious adverse events (SAEs), nb | 4 |
| Heart failure/pulmonary oedema | 1 |
| Pulmonary infiltrates | 1 |
| Hypoxaemia/respiratory insufficiency | 2 |
| Treatment-related SAEs, n | 0 |
aAll four events occurred in one patient (no. 001); bthe four SAEs occurred in two patients (no. 002 and no. 005).
ALT = alanine aminotransferase; AST = aspartate aminotransferase.